Abstract
Tissue CEA, TPA, and CA 19.9 concentrations from samples of surgical specimens were measured in 47 evaluable colorectal cancer patients (median follow-up, 20 months, 13 recurrences) and correlated with individual patient follow-up status. The quantitative method appeared to be sensitive, easily reproducible, and standardizable. The tissue marker concentration was analyzed by means of the multivariate discriminant analysis, to evaluate the risk of relapse in each patient; the tumor CEA (CEAT) showed the best discriminant capacity (P=.005). The relative Fisher function provided a reliable prognostic patient index, independently of other recognized prognostic factors (Dukes' stage and cellular differentiation grade). The Cox model showed a statistical significance analyzing the tumor (T) and healthy mucosa (M) CEA values (P=.001 andP=.006, respectively). The combination of these two variables allowed for identification of three classes of patients according to CEA T and M threshold values of 216 and 85 ng/mg of protein, respectively, and different disease-free curves were obtained for each group. The two-year disease-free rate was 81 percent for patients with low values of both CEA T and M, and 21.4 percent for the group with both values above these thresholds (P=.0008). In the third class (CEA T or M higher than the reported cut-off levels), the two-year disease-free rate was 65.9 percent.
Similar content being viewed by others
References
Gold P, Freedman SO. Cellular location of carcinoembryonic antigens of the human digestive system. Cancer Res 1968;28:1331–3.
Goslin R, O'Brien MJ, Steele G, et al. Correlation of plasma CEA and CEA tissue staining in poorly differentiated colorectal cancer. Am J Med 1981;71:246–53.
Cunningham L, Stocking B, Halter SA, Kalemeris G. Immunoperoxidase staining of carcinoembryonic antigen as a prognostic indicator in colorectal carcinoma. Dis Colon Rectum 1986;29:111–6.
Au FC, Stein BS, Gennaro AR, Tyson RR. Tissue CEA in colorectal carcinoma. Dis Colon Rectum 1984;27:16–8.
Bombardieri E, Saccani Jotti G, Cocciolo MG, et al. Tissue polypeptide antigen in colon tumors: serum levels and immunohistochemical localization. Cancer Detect Prev 1985;8:219–26.
Midiri G, Amanti C, Benedetti M, et al. CEA tissue staining in colorectal cancer patients. Cancer 1985;55:2624–9.
Rognum T, Elgyo K, Brandtzaeg P, Orjasaeter H, Bergan A. Plasma carcinoembryonic antigen concentrations and immunohistochemical patterns of epithelial marker antigens in patients with large bowel carcinoma. J Clin Pathol 1982;35:922–33.
Hamada Y, Yamamura M, Hioki K, Yamamoto M, Nagura H, Watanabe K. Immunohistochemical study of carcinoembryonic antigen in patients with colorectal cancer. Cancer 1985;55:136–41.
Ahen DJ, Nakane PK, Brown WR. Ultrastructural localization of carcinoembryonic antigen in normal intestine and colon cancer. Cancer 1982;49:2077–90.
O'Brien MJ, Zamcheck N, Burke B, Kirkham SE, Saravis CA, Gottlieb LS. Immunocytochemical localization of carcinoembryonic antigen in benign and malignant colorectal tissues. Am J Clin Pathol 1981;75:283–90.
Nakopoulou L, Zinozi M, Theodoropoulos G, Papacharalampous N. Carcinoembryonic antigen detection by immunocytochemical methods in carcinomas of the colon and stomach. Dis Colon Rectum 1983;26:269–74.
Border M, Michiels R, Martin F. Detection by immunofluorescence of carcinoembryonic antigen in colonic carcinoma other malignant or benign tumors and non-cancerous tissues. Digestion 1973;9:106–15.
Arends JW, Wiggers T, Scutte B, et al. Monoclonal antibody (1116 NS 19-9) defined monosialogangloside, (GICA) in colorectal carcinoma in relation to stage, histopathology and DNA flow cytometry. Int J Cancer 1983;32:289–93.
Arends JW, Wiggers T, Verstijnen C, Hilgers J, Bosman FT. Gastrointestinal cancer-associated antigen (GICA) immunoreactivity in colorectal carcinoma in relation to patient survival. Int J Cancer 1984;34:193–6.
Atkinsons BF, Ernst CS, Herlyn M, Steplewski Z, Sears HF, Koprowski H. Gastrointestinal cancer-associated antigen in immunoperoxidase assay. Cancer Res 1982;42:4820–3.
Olding LB, Thurin J, Svalander C, Koprowski H. Monoclonal antibody NS-19-9. Int J Cancer 1985;36:187–92.
Boyd CR, Bivens BA, Kashmiri R, Parker JC, Meeker WR. Plasma CEA, tumor CEA and tumor histology. J Surg Oncol 1976;8:507–12.
Wagener C, Muller-Wallraf R, Nisson S, Groner J, Breuer H. Localization and concentration of carcinoembryonic antigen (CEA) in gastrointestinal tumors correlation with CEA levels in plasma. J Natl Cancer Inst 1981;67:539–47.
Go VL, Spencer RJ, Ravry MJ, Shorter RG, Huizenga KA. Carcinoembryonic antigen (CEA) in malignant and inflammatory colonic tissue. Gastroenterology 1973;64:734.
Martin F, Martin MS. Radioimmunoassay of carcinoembryonic antigen in extracts of human colon and stomach. Int J Cancer 1972;9:641–7.
Khoo SK, Warner NL, Lie JT, Mackay IR. Carcinoembryonic antigen activity of tissue extracts: a quantitative study of malignant and benign neoplasm, cirrhotic liver, normal, adult and fetal organs. Int J Cancer 1973;11:681–7.
Huitric E, Laumonier R, Burtin P, Von Kleist S, Chavanel G. An optical and ultrastructural study of the localization of carcinoembryonic antigen (CEA) in normal and cancerous human rectocolonic mucosa. Lab Invest, 1976;34:97–107.
Wiggers T, Arends JW, Verstinjnen C, Moerkerk PM, Bosman FT. Prognostic significance of CEA immunoreactivity patterns in large bowel carcinoma tissue. Br J Cancer 1986;54:409–14.
Cavaliere R, Cavallari A, Casale V, et al. An evaluation of combined tissue CEA, TPA and CA 19.9 sampling in colorectal cancer patients. 14th International Cancer Congress Budapest 1986;3:974 (no. 3748).
Cavaliere R, De Peppo F, Castaldo P, et al. A multivariate discriminant analysis of tissue CEA, TPA and CA 19.9 quantitative determination in colorectal cancer patients. Proceedings of 32nd Congress of the Société Internationale de Chirurgie 1987 [Abstract no A 11.2, p. 28].
Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951;193:265–75.
Castelli M, Sega FM, Sciarretta F, Casale V, Coloni F, Sega E. The biological and clinical significance of tumor markers in tissue extracts. Cancer Detect Prev 1983;6:61–6.
Gion M, Mione R, Dittadi R, Fasan S, Pallini A, Bruscagnini G. Carcinoembryonic antigen, ferritin and tissue polypeptide antigen in serum and tissue: relationship with the receptor content in breast carcinoma. Cancer 1986;57:917–22.
Yalow RS, Berson SA. General principles of radioimmunoassay. In: Haynes RL, Goswitz FA, Murphy BE, eds. Radioisotopes in medicine: in vitro studies. Oak Ridge: US Atomic Energy Commission Conference 671111, 1968:22–30.
Bouroche JM, Saporta G. L'analyse des données. P.U.F. Paris 1980.
Caillez F, Pages JP. Introduction a l'analyse des données. S.M.A.S.H. Paris 1976:393–422.
Romedere JM. Methodes et programmes d'analyse discriminante. Paris: Dunoud, 1973.
Cox DR. Regression models and life tables (with discussion). J R Stat Soc [Series B] 1972;34:187–220.
Berkson J, Gage RP. Calculation of survival rates for cancer. Mayo Clin Proc 1950;25:270.
Lee E, Desu M. A computer program for comparing samples with right-sensored data. Computer Methods Programs Biomed 1972;2:315–21.
Lebart L, Morineau A, et al. S.P.A.D. Version 1985, Paris 1985.
Dixon WJ, et al. BMDP: Biomedical Computer Programs. Berkeley: University of California Press, 1983.
Brown B, Schimek M, Walker H, Wright P. Survival. In: Norusis MJ, ed. SPSSX: Statistical Package for the Social Sciences Plus. New York: McGraw-Hill, 1983.
Rognum T, Thornd E, Elgjo K, Brandtzaeg P, Orjasaeter H, Nygaard K. Large bowel carcinomas with different ploidy, related to secretory component IGA and CEA in epithelium and in plasma. Br J Cancer 1985;45:921.
Steplewski Z, Chang TH, Herlyn M, Koprowski H. Release of monoclonal antibody-defined antigens by human carcinoma and melanoma cells. Cancer Res 1981;41:2723–7.
Booth SN, King JP, Leonard JC, Dukes PW. Serum carcinoembryonic antigen in clinical disorders. Gut 1973;14:794–9.
Lowenstein MS, Zamcheck H. Carcinoembryonic antigen (CEA) levels in benign gastrointestinal disease states. Cancer 1978;42:1412–8.
Moore TL, Kupchik HZ, Marcon N, Zamchek N. Carcinoembryonic antigen assay in cancer of the colon and pancreas and other digestive tract disorders. Am J Dig Dis 1971;16:1–7.
Goldemberg DM, Sharkey RM, Primus FJ. Immunocytochemical detection of carcinoembryonic antigen in conventional histopathology specimens. Cancer 1978;42:1546–53.
Author information
Authors and Affiliations
Additional information
Read at the 32nd World Congress of Surgery, Sydney, Australia, September 20 to 26, 1987.
Partially supported by C.N.R. Progetto Finalizzato Oncologia, grant no. 84.00849.44.
About this article
Cite this article
Cosimelli, M., De Peppo, F., Castelli, M. et al. Multivariate analysis of a tissue CEA, TPA, and CA 19.9 quantitative study in colorectal cancer patients. Dis Colon Rectum 32, 389–397 (1989). https://doi.org/10.1007/BF02563690
Issue Date:
DOI: https://doi.org/10.1007/BF02563690